Gynion is commercializing an ablative gel platform that transforms complex gynecologic procedures into simple, affordable in-office care worldwide. Our platform supports a pipeline of products across multiple multi-billion-dollar women’s health markets, with an initial focus on Clarablex for the treatment of cervical intraepithelial neoplasia (CIN) to prevent cervical cancer and Menorrx for heavy menstrual bleeding (HMB).